Literature DB >> 25323000

Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia.

Stefan Van der Mussele1, Peter Mariën, Jos Saerens, Nore Somers, Johan Goeman, Peter P De Deyn, Sebastiaan Engelborghs.   

Abstract

OBJECTIVES: The aim of this study is to determine the prevalence of psychosis in mild cognitive impairment (MCI, Petersen's criteria) and patients with Alzheimer's dementia, and to characterize the associated behavioral and psychological signs and symptoms of dementia (BPSD).
METHOD: A cross-sectional analysis of baseline data from an ongoing, prospective, longitudinal study on BPSD was performed, including 270 MCI and 402 AD patients. BPSD assessment was performed through Middelheim Frontality Score (MFS), Behave-AD, Cohen-Mansfield Agitation Inventory (CMAI) and Cornell Scale for Depression in Dementia (CSDD). Psychosis was considered to be clinically relevant when delusions and/or hallucinations occurred at least once in the last two weeks prior to the BPSD assessment.
RESULTS: The prevalence of psychosis in AD (40%) was higher than in MCI (14%; p < 0.001). AD patients with psychosis showed more severe frontal lobe, BPSD, agitation and depressive symptoms (MFS, Behave-AD, CMAI and CSDD total scores), whereas MCI patients with psychosis only showed more severe frontal lobe and physically non-aggressive agitated behavior. In addition, only in psychotic AD patients, all BPSD and types of agitation were more severe compared to non-psychotic AD patients. Comparing MCI and AD patients, MCI patients with psychosis did not show more severe frontal lobe, behavioral and psychological (Behave-AD), depressive symptoms or agitation than AD patients without psychosis.
CONCLUSION: AD patients clearly display psychosis associated BPSD, whereas MCI patients only display more severe frontal lobe symptoms and physically non-aggressive agitated behavior, but also less pronounced than in AD.

Entities:  

Keywords:  AD; BPSD; MCI; delusions; hallucinations; psychosis

Mesh:

Year:  2014        PMID: 25323000     DOI: 10.1080/13607863.2014.967170

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  6 in total

Review 1.  Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  David Wolinsky; Karina Drake; Jolene Bostwick
Journal:  Curr Psychiatry Rep       Date:  2018-10-27       Impact factor: 5.285

2.  The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.

Authors:  Alain D Dekker; Silvia Sacco; Angelo Carfi; Bessy Benejam; Yannick Vermeiren; Gonny Beugelsdijk; Mieke Schippers; Lyanne Hassefras; José Eleveld; Sharina Grefelman; Roelie Fopma; Monique Bomer-Veenboer; Mariángeles Boti; G Danielle E Oosterling; Esther Scholten; Marleen Tollenaere; Laura Checkley; André Strydom; Gert Van Goethem; Graziano Onder; Rafael Blesa; Christine Zu Eulenburg; Antonia M W Coppus; Anne-Sophie Rebillat; Juan Fortea; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation.

Authors:  Tobi Van den Bossche; Kristel Sleegers; Elise Cuyvers; Sebastiaan Engelborghs; Anne Sieben; Arne De Roeck; Caroline Van Cauwenberghe; Steven Vermeulen; Marleen Van den Broeck; Annelies Laureys; Karin Peeters; Maria Mattheijssens; Mathieu Vandenbulcke; Rik Vandenberghe; Jean-Jacques Martin; Peter P De Deyn; Patrick Cras; Christine Van Broeckhoven
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

4.  Impairment of fine motor dexterity in mild cognitive impairment and Alzheimer's disease dementia: association with activities of daily living.

Authors:  Jonas J de Paula; Maicon R Albuquerque; Guilherme M Lage; Maria A Bicalho; Marco A Romano-Silva; Leandro F Malloy-Diniz
Journal:  Braz J Psychiatry       Date:  2016-04-08       Impact factor: 2.697

5.  Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression.

Authors:  Farid Chekani; Holly M Holmes; Michael L Johnson; Hua Chen; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drug Healthc Patient Saf       Date:  2020-01-31

6.  Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.

Authors:  Amber Nous; Mandy Melissa Jane Wittens; Yannick Vermeiren; Peter Paul De Deyn; Christine Van Broeckhoven; Guy Nagels; Ilse Smolders; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.